These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32629809)

  • 21. Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures.
    Egaña JT; Zambrano C; Nuñez MT; Gonzalez-Billault C; Maccioni RB
    Biometals; 2003 Mar; 16(1):215-23. PubMed ID: 12572681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.
    Forloni G; Artuso V; La Vitola P; Balducci C
    Mov Disord; 2016 Jun; 31(6):771-81. PubMed ID: 27030592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
    Majd S; Power JH; Grantham HJ
    BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of transglutaminase and other stress proteins during neurodegenerative processes.
    Caccamo D; Currò M; Condello S; Ferlazzo N; Ientile R
    Amino Acids; 2010 Feb; 38(2):653-8. PubMed ID: 19960212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.
    Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA
    J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.
    Chouhan AK; Guo C; Hsieh YC; Ye H; Senturk M; Zuo Z; Li Y; Chatterjee S; Botas J; Jackson GR; Bellen HJ; Shulman JM
    Acta Neuropathol Commun; 2016 Jun; 4(1):62. PubMed ID: 27338814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanisms of neurodegeneration in Alzheimer's disease].
    Jovanović Z
    Med Pregl; 2012; 65(7-8):301-7. PubMed ID: 22924250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
    Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
    Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
    Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
    Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
    Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.
    Uranga RM; Salvador GA
    Oxid Med Cell Longev; 2018; 2018():2850341. PubMed ID: 29581821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordination and redox properties of copper interaction with α-synuclein.
    Valensin D; Dell'Acqua S; Kozlowski H; Casella L
    J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.
    Deger JM; Gerson JE; Kayed R
    Aging Cell; 2015 Oct; 14(5):715-24. PubMed ID: 26053162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.